Advertisement

Calcium-Binding Proteins in Type I Allergy: Elicitors and Vaccines

  • Rudolf Valenta
  • Anna Twardosz
  • Ines Swoboda
  • Brigitte Hayek
  • Susanne Spitzauer
  • Dietrich Kraft

Abstract

Type I allergy is an immunologically-mediated hypersensitivity disease with complex genetic background affecting almost 25% of the population (Kay, 1997; Lockey and Bukantz, 1998). As a major feature of their disease, allergic patients produce IgE antibodies against per se mostly harmless antigens (i.e., allergens) which, after allergen-binding, can activate effector and inducer cells of the atopic immune response (Ravetch and Kinet, 1991; Beaven and Metzger, 1993; Bieber, 1996; Stingi and Maurer, 1997). Depending on the site and duration of allergen contact and the type of immune cells involved, the manifestations of Type I allergy may greatly vary (e.g., allergic rhinitis, conjunctivitis, asthma, dermatitis, gastrointestinal disease). Progress made in the field of molecular allergen characterization has revealed that calcium-binding proteins from many sources are frequent targets for IgE antibodies of allergic patients and thus can act as widely spread elicitors of Type I allergy (Valenta et al., 1998). Calcium-binding allergens from different sources share sequence and structural similarities. Therefore, patients who are cross-sensitized to calcium-binding allergens can exhibit allergic symptoms after exposure to many allergen sources. Calcium-depletion experiments indicate that IgE antibodies of sensitized individuals recognize preferentially the calcium-bound forms of the allergens whereas the apoforms are poorly recognized. This fact opens possibilities to employ genetic engineering and synthetic peptide chemistry for the production of hypoallergenic apoforms which may be used for therapeutic vaccination against Type I allergy with a reduced rate of anaphylactic side effects.

Keywords

Allergic Patient Pollen Allergen Allergy Immunol Allergen Immunotherapy Olive Pollen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aas, K. and Jebsen, J.W., 1967, Studies of hypersensitivity to fish. Partial purification and crystallization of a major allergenic component of cod, Int. Arch. Allergy 32, 1–20.PubMedCrossRefGoogle Scholar
  2. Akdis, C.A. and Blaser, K., 1999, IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy, FASEB J. 13, 603–609.PubMedGoogle Scholar
  3. Ball, T., Sperr, W.R., Valent, P., Lidholm, J., Spitzauer, S., Ebner, C., Kraft, D. and Valenta, R., 1999, Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy, Eur. J. Immunol 29, 2026–2036.PubMedCrossRefGoogle Scholar
  4. Batanero, E., Villalba, M., Ledesma, A., Puente, X.S. and Rodriguez, R., 1996, Ole e 3, an olive tree allergen, belongs to a widespread family of pollen proteins, Eur. J. Biochem. 241, 772–778.PubMedCrossRefGoogle Scholar
  5. Beaven, M.A. and Metzger, H., 1993, Signal transduction by Fc receptors: The Fc epsilon RI case, Immunol Today 14, 222–226.PubMedCrossRefGoogle Scholar
  6. Bieber, T., 1996, Fc epsilon RI on antigen-presenting cells, Curr. Opin. Immunol. 8, 773–777.PubMedCrossRefGoogle Scholar
  7. Bousquet, J., Lockey, R., Mailing, H.J. and the WHO Panel Members, 1998a, Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper, J. Allergy Clin. Immunol. 102, 558–562.PubMedCrossRefGoogle Scholar
  8. Bousquet, J., Lockey, R. and Mailing, HJ., 1998b, WHO position paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases, Allergy 53, 1–42.Google Scholar
  9. Brewbaker, J.L. and Kwack, B.H., 1963, The essential role of calcium ion in pollen germination and pollen tube growth, Am. J. Both. 50, 859–865.CrossRefGoogle Scholar
  10. Bugajska-Schretter, A., Elfman, L., Fuchs, T., Kapiotis, S., Rumpold, H., Valenta, R. and Spitzauer, S., 1998, Parvalbumin, a cross-reactive fish allergen, contains IgE-binding epitopes sensitive to periodate treatment and Ca2+ depletion, J. Allergy Clin. Immunol. 101, 67–74.PubMedCrossRefGoogle Scholar
  11. Bugajska-Schretter, A., Grote, M., Vangelista, L., Valent, P., Sperr, W.R., Rumpold, H., Pastore, A., Reichelt, R., Valenta, R. and Spitzauer, S., 2000, Purification, biochemical, and immunological characterization of a major food allergen: Different immunoglobulin E recognition of the apo-and calcium-bound form of carp parvalbumin, Gut 46, 661–669.PubMedCrossRefGoogle Scholar
  12. Casolaro, S., Georas, S.N., Song, Z. and Ono, S.J., 1996, Biology and genetics of atopic disease, Curr. Opin. Immunol. 8, 796–803.PubMedCrossRefGoogle Scholar
  13. Coffee, C.J. and Bradshaw, R.A., 1973, Carp muscle calcium-binding protein. I. Characterization of the tryptic peptides and the complete amino acid sequence of component B, J. Biol. Chem. 248, 3302–3312.Google Scholar
  14. Cooke, R., Barnard, J., Hebald, S. and Stull, A., 1935, Serological evidence on immunity with co-existing sensitization in a type of human allergy, hay fever, J. Exp. Med. 62, 733–750.PubMedCrossRefGoogle Scholar
  15. Creticos, P.S., Adkinson, N.F., Jr., Kagey-Sobotka, A., Proud, D., Meier, H.L., Naclerio, R.M., Lichtenstein, L.M. and Norman, P.S., 1985, Nasal challenge with ragweed in hay fever patients: Effect of immunotherapy, J. Clin. Invest. 76, 2247–2253.PubMedCrossRefGoogle Scholar
  16. Desreumaux, P. and Capron, M., 1996, Eosinophils in allergic reactions, Curr. Opin. Immunol. 8, 790–795.PubMedCrossRefGoogle Scholar
  17. Durham, S.R. and Till, S.J., 1998, Immunological changes associated with allergen immunotherapy, J. Allergy Clin. Immunol. 102, 157–164.PubMedCrossRefGoogle Scholar
  18. Durham, S.R., Ying, S., Varney, VA., Jacobson, M.R., Sudderick, R.M., Mackay, LS., Kay, A.B. and Hamid, Q.A., 1996, Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ, J. Allergy Clin. Immunol. 97, 1356–1365.PubMedCrossRefGoogle Scholar
  19. Engel, E., Richter, K., Obermeyer, G., Briza, P., Kungl, A.J., Simon, B., Auer, M., Ebner, C., Rheinberger, HJ., Breitenbach, M. and Ferreira, F., 1997, Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains, J. Biol. Chem. 272, 28630–28637.PubMedCrossRefGoogle Scholar
  20. Elsayed, S. and Aas, K., 1971, Characterization of a major allergen (cod). Observation on effect of denaturation on the allergenic activity, J. Allergy 47, 283–291.PubMedGoogle Scholar
  21. Furin, M.M., Norman, P.S., Creticos, P.S., Proud, D., Kagey-Sobotka, A., Lichtenstein, L.M. and Naclerio, R.M., 1991, Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity, J. Allergy Clin. Immunol. 88, 27–32.PubMedCrossRefGoogle Scholar
  22. Grote, M., Hayek, B., Reichelt, R., Kraft, D. and Valenta, R., 1999, Immunogold electron microscopic localization of the crossreactive two EF-hand calcium-binding birch pollen allergen Bet v 4 in dry and rehydrated birch pollen, Int. Arch. Allergy Immunol. 120, 287–294.PubMedCrossRefGoogle Scholar
  23. Haas, H., Falcone, F.H., Holland, M.J., Schramm, G., Haisch, K., Gibbs, B.F., Bufe, A. and Schlaak, M., 1999, Early interleukin-4: ist role in the switch towards a Th2 response and IgE-mediated allergy, Int. Arch. Allergy Immunol. 119, 86–94.PubMedCrossRefGoogle Scholar
  24. Hayek, B., Vangelista, L., Pastore, A., Sperr, W.R., Valent, P., Vrtala, S., Niederberger, V., Twardosz, A., Kraft, D. and Valenta, R., 1998, Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: Structural basis for calcium-modulated IgE recognition, J. Immunol. 161, 7031–7039.PubMedGoogle Scholar
  25. Heinzmann, C.W. and Hunziker, W., 1991, Intracellular calcium-binding proteins: more sites than insights, Trends Biochem. Sci. 16, 98–103.CrossRefGoogle Scholar
  26. Henderson, L.L., Larson, J.B. and Gleich, G.L., 1975, Maximal rise in IgE antibody following ragweed pollination season, J. Allergy Clin. Immunol. 55, 10–15.PubMedCrossRefGoogle Scholar
  27. Herzberg, O., Moult, J. and James, M.N., 1986, A model for the Ca2+ induced conformational transition of troponin C. A trigger for muscle contraction, J. Biol. Chem. 261, 2638–2644.PubMedGoogle Scholar
  28. Ikura, M., 1996, Calcium binding and conformational response in EF-hand proteins, Trends Biochem. Sci. 21, 14–17.PubMedGoogle Scholar
  29. Ishizaka, K., Ishizaka, T. and Hornbrook, M.M., 1966, Physicochemical properties of human reagirnc antibody, J. Immunol. 97, 840–845.PubMedGoogle Scholar
  30. Johansson, S.G.O. and Bennich, H., 1967, Immunological studies of an atypical (myeloma) immunoglobulin, Immunology 13, 381–394.PubMedGoogle Scholar
  31. Jutel, M., Pichler, W.J., Skrbic, D., Urwyler, A., Dahinden, C. and Müller, U.R., 1995, Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures, J. Immunol. 154, 4187–4194.PubMedGoogle Scholar
  32. Kawasaki, H. and Kretsinger, R.H., 1994, Calcium-binding proteins, in Protein Profile 1, H. Kawasaki and R.H. Kretsinger (eds.), Academic Press, San Diego, pp. 343–390.Google Scholar
  33. Kawasaki, H., Nakayama, S. and Kretsinger, R.H., 1998, Classification and evolution of EF-hand proteins, Biometals 11, 277–295.PubMedCrossRefGoogle Scholar
  34. Kay, A.B., 1997, Allergy and Allergic Diseases, Blackwell Science, Oxford.Google Scholar
  35. Kretsinger, R.H. and Nockolds, C.E., 1973, Carp muscle calcium-binding protein. II. Structure determination and general description, J. Biol. Chem. 248, 3313–3326.PubMedGoogle Scholar
  36. Laberge, M., Wright, W.W., Sudhakar, K., Liebman, P.A. and Vanderkooi, J.M., 1997, Conformational effects of calcium release from parvalbumin: Comparison of computational simulations with spectroscopic investigations, Biochemistry 36, 5363–5371.PubMedCrossRefGoogle Scholar
  37. Ledesma, A., Villalba, M., Batanero, E. and Rodriguez, R., 1998, Molecular cloning and expression of active Ole e 3, a major allergen from olive-tree pollen and member of a novel family of Ca2+-binding proteins (polcalcins) involved in allergy, Eur. J. Biochem. 258, 454–459.PubMedCrossRefGoogle Scholar
  38. Ledesma, A., Villalba, M. and Rodriguez, R., 2000, Cloning, expression and characterization of a novel four EF-hand Ca2+-binding protein from olive pollen with allergenic activity, FEBS Lett. 466, 192–196.PubMedCrossRefGoogle Scholar
  39. Lindstroem, C.D.V., van Do, T., Hordvik, I., Endresen, C. and Elsayed, S., 1996, Cloning of two distinct cDNAs encoding parvalbumin, the major allergen of atlantic salmon (Salmo salar), Scand. J. Immunol. 44, 335–344.CrossRefGoogle Scholar
  40. Lockey, R.F. and Bukantz, S.C. (eds.), 1998, Allergen Immunotherapy, 2nd edition, Marcel Dekker, New York.Google Scholar
  41. Maurer, D., Ebner, C., Reininger, B., Fiebiger, E., Kraft, D., Kinet, J.P. and Stingi, G., 1995, The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation, J. Immunol 154, 6285–6290.PubMedGoogle Scholar
  42. Maurer, D., Fiebiger, E., Ebner, C., Reininger, B., Fischer, G.F., Wichlas, S., Jouvin, M.H., Schmitt-Egenolf, M., Kraft, D., Kinet, J.P. and Stingi, G., 1996, Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha-and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation, J. Immunol. 157, 607–616.PubMedGoogle Scholar
  43. McGibbon, A.M. and Lee, T.D., 1995, Structural characteristics of the Ascaris allergen, ABA-1, Parasite 2, 41–48.PubMedGoogle Scholar
  44. Mudde, G.C., van Reijsen, F.C., Boland, G.J., de Gast, G.C., Bruijnzeel, P.L. and Bruijnzeel-Koomen, C.A., 1990, Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE, Immunology 69, 335–341.PubMedGoogle Scholar
  45. Natter, S., Seiberler, S., Hufnagl, P., Binder, B.R., Hirschl, A.M., Ring, J., Abeck, D., Schmidt, T., Valent, P. and Valenta, R., 1998, Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients, FASEB J. 12, 1559–1569.PubMedGoogle Scholar
  46. Niederberger, V., Hayek, B., Vrtala, S., Laffer, S., Twardosz, A., Vangelista, L., Sperr, W.R., Valent, P., Rumpold, H., Kraft, D., Ehrenberger, K., Valenta, R. and Spitzauer, S., 1999, Calcium-dependent immunoglobulin E recognition of the apo-and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7, FASEB J. 13, 843–856.PubMedGoogle Scholar
  47. Okada, T., Swoboda, I., Bhalla, P.L., Toriyama, D. and Singh, M.B., 1998, Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy, FEBS Lett. 434, 255–260.PubMedCrossRefGoogle Scholar
  48. Otsuka, H., Mezawa, A., Ohnishi, M., Okubo, K., Sehi, H. and Okuda, M., 1991, Changes in nasal metachromatic cells during allergen immunotherapy, Clin. Exp. Allergy 21, 115–120.PubMedCrossRefGoogle Scholar
  49. Prausnitz, C. and Küstner, H., 1921. Studien über die Überempfindlichkeit, Zentralbl. Bakteriol. 86, 160–169.Google Scholar
  50. Pritchard, D.I., Brown, A., Kasper, G., McElroy, P., Loukas, A., Hewitt, C., Berry, C., Fullk-rug, R. and Beck, E., 1999, A hookworm allergen which strongly resembles calreticulin, Parasite Immunol. 21, 439–450.PubMedCrossRefGoogle Scholar
  51. Rak, S., Rowhagen, O. and Venge, P., 1998, The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients, J. Allergy Clin. Immunol 82, 470–480.CrossRefGoogle Scholar
  52. Rautiainen, J., Rytkonen, M., Parkkinen, S., Pentikainen, J., Linnala-Kamkkunen, A., Virtanen, T., Pelkonen, J. and Mantyjarvi, R., 1995, cDNA cloning and protein analysis of a bovine dermal allergen with homology to psoriasin, J. Invest. Dermatol 105, 660–663.PubMedCrossRefGoogle Scholar
  53. Ravetch, J.V. and Kinet, J.P., 1991, Fc receptors, Annu. Rev. Immunol. 9, 457–492.PubMedCrossRefGoogle Scholar
  54. Rocklin, R.E., Sheffer, A., Greineder, D.K. and Melmon, K.L., 1980, Generation of antigen-specific supressor cells during allergy desensitization, New Engl. J. Med. 302, 1213–1219.PubMedCrossRefGoogle Scholar
  55. Santiago, M.L., Hafalla, J.C.R., Kurtis, J.D., Aligui, G.L., Wiest, P.M., Olveda, R.M., Olds, G.R., Dunne, D.W. and Ramirez, B.L., 1998, Identification of the Schistosoma japonicum 22.6 kD antigen as a major target of the human IgE response: Similarity of IgE-binding epitopes to allergen peptides, Int. Arch. Allergy Immunol 117, 94–106.PubMedCrossRefGoogle Scholar
  56. Secrist, H., Chelen, C.J., Wen, Y., Marshall, J.D. and Umetsu, D.T., 1993, Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals, J. Exp. Med. 178, 2123–2130.PubMedCrossRefGoogle Scholar
  57. Secrist, H., DeKruyff, R.H. and Umetsu, D.T., 1995, Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type, J. Exp. Med. 181, 1081–1089.PubMedCrossRefGoogle Scholar
  58. Segal, D.M., Taurog, J.D. and Metzger, H., 1977, Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation, Proc. Natl. Acad. Sci. USA 74, 2993–2997.PubMedCrossRefGoogle Scholar
  59. Seiberler, S., Scheiner, O., Kraft, D. and Valenta, R., 1992, Homology of two cDNAs coding for birch pollen allergens with calmodulin: Protein-bound Ca2+ affects the IgE-binding capacity, Int. Arch. Allergy Immunol. 99, 380–381.CrossRefGoogle Scholar
  60. Seiberler, S., Scheiner, O., Kraft, D., Lonsdale, D. and Valenta, R., 1994, Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2+ binding proteins: Specific expression in mature pollen and dependence of patients’ IgE binding on protein-bound Ca2+, EMBO J. 13, 3481–3486.PubMedGoogle Scholar
  61. Singh, M.B., de-Weerd, N. and Bhalla, P.L., 1999, Genetically engineered plant allergens with reduced anaphylactic activity, Int. Arch. Allergy Immunol. 119, 75–85.PubMedCrossRefGoogle Scholar
  62. Smith, P.M., Xu, H., Swoboda, I. and Singh, M.B., 1997, Identification of a Ca2+ binding protein as a new Bermuda grass pollen allergen Cyn d 7: IgE cross-reactivity with oilseed rape pollen allergen Bra r 1, Int. Arch. Allergy Immunol. 114, 265–271.PubMedCrossRefGoogle Scholar
  63. Stingi, G. and Maurer, D., 1997, IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells, Int. Arch. Allergy Immunol. 113, 24–29.CrossRefGoogle Scholar
  64. Strynadka, N.C.J. and James, M.N.G., 1991, Towards an understanding of the effects of calcium on protein structure and function, Curr. Opin. Struct. Biol. 1, 905–914.CrossRefGoogle Scholar
  65. Suphioglu, C., Ferreira, F. and Knox, R.B., 1997, Molecular cloning and immunological characterization of Cyn d 7, a novel calcium-binding allergen from Bermuda grass pollen, FEBS Lett. 402, 167–172.PubMedCrossRefGoogle Scholar
  66. Tinghino, R., Barletta, B., Palumbo, S., Afferni, C., Iacovacci, P., Mari, A., Di Felici, G. and Pini, C., 1998, Molecular characterization of a cross-reactive Juniperus oxycedrus pollen allergen, Jun o 2: A novel calcium-binding allergen, J. Allergy Clin. Immunol. 101, 772–777.PubMedCrossRefGoogle Scholar
  67. Toriyama, K., Okada, T., Watanabe, M., Ide, T., Ashida, T., Xu, H. and Singh, M.B., 1995, A cDNA clone encoding an IgE-binding protein from Brassica anther has significant sequence similarity to Ca2+-binding proteins, Plant. Mol. Biol. 29, 1157–1165.PubMedCrossRefGoogle Scholar
  68. Trave, G., Lacombe, P.J., Pfuhl, M., Saraste, M. and Pastore, A., 1995, Molecular mechanism of the calcium-induced conformational change in the spectrin EF-hands, EMBO J. 14, 4922–4931.PubMedGoogle Scholar
  69. Twardosz, A., Hayek, B., Seiberler, S., Vangelista, L., Elfman, L., Grönlund, H., Kraft, D. and Valenta, R., 1997, Molecular characterization, expression in Escherichia coli and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4, Biochem. Biophys. Res. Comm. 239, 197–204.PubMedCrossRefGoogle Scholar
  70. Valenta, R. and Kraft, D., 1995, Recombinant allergens for diagnosis and therapy of allergic diseases, Curr. Opin. Immunol. 7, 751–756.PubMedCrossRefGoogle Scholar
  71. Valenta, R., Hayek, B., Seiberler, S., Bugajska-Schretter, A., Niederberger, V., Twardosz, A., Natter, S., Vangelista, L., Pastore, A., Spitzauer, S. and Kraft, D., 1998, Calcium-binding allergens: From plants to man, Int. Arch. Allergy Immunol. 117, 160–166.PubMedCrossRefGoogle Scholar
  72. Valenta, R., Lidholm, J., Niederberger, V., Hayek, B., Kraft, D. and Grönlund, H., 1999a, The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT), Clin. Exp. Allergy 29, 896–904.PubMedCrossRefGoogle Scholar
  73. Valenta, R., Vítala, S., Focke-Tejkl, M., Bugajska-Schretter, A., Ball, T., Twardosz, A., Spitzauer, S., Grönlund, H. and Kraft, D, 1999b, Genetically engineered and synthetic allergen derivatives: Candidates for vaccination against Type I allergy, Biol. Chem. 380, 815–824.PubMedCrossRefGoogle Scholar
  74. Valenta, R., Seiberler, S., Natter, S., Mahler, V., Mossabeb, R., Ring, J. and Stingi, G., 2000, Autoallergy: A pathogenetic factor in atopic dermatitis?, J. Allergy Clin. Immunol. 105, 432–437.PubMedCrossRefGoogle Scholar
  75. Vercelli, D., De Monte, L., Monticelli, S., Di Bartolo, C. and Agresti, A., 1998, To E or not to E? Can IL-4-induced B cell choose between IgE and IgG4?, Int. Arch. Allergy Immunol. 116, 1–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Rudolf Valenta
    • 1
  • Anna Twardosz
    • 1
  • Ines Swoboda
    • 2
  • Brigitte Hayek
    • 1
  • Susanne Spitzauer
    • 2
  • Dietrich Kraft
    • 1
  1. 1.Department of Pathophysiology, Vienna General HospitalUniversity of ViennaAustria
  2. 2.Department of Medical and Clinical Chemistry, Vienna General HospitalUniversity of ViennaAustria

Personalised recommendations